Bionano Genomics Inc. (BNGO)

Business: Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function.

IPO Date: 21-Aug-2018

Pres, CEO, Sec. & Director: Dr. Robert Erik Holmlin M.B.A., Ph.D.

Chief Operating Officer: Mr. Mark Oldakowski

Listing: NASDAQ: BNGO

Country: United States

Headquarters: San Diego, CA

Website: https://www.bionanogenomics.com

Market cap: $469.31 Mln

Revenue (TTM): $20.51 Mln

Earnings (TTM): $-92.44 Mln

Cash: $216.47 Mln

Total Debt: $11.12 Mln

Insider's Holding: 1.92%

Liquidity: Low

52 Week range: $1.16 - 7.84

Shares outstanding: 289,696,992

6 Years Aggregate:

• CFO: $-204.03 Mln
• EBITDA: $-182.03 Mln
• Net Profit: $-204.07 Mln